November 06, 2024 article Open access Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy Frontiers in Immunology DOI: 10.3389/fimmu.2024.1433119 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 3 References 2 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses 2021 Cancer Immunology Immunotherapy article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents 26 citations Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo 2023 Cellular and Molecular Life Sciences article Immunology and Microbiology Immunotherapy and Immune Responses Open access 4 citations 2 results